# Blessings International – FDA Inspection, May 14, 2026

Source: https://www.keypedia.com/records/fda_inspections/blessings-international/437dacb6-585e-4afa-8e87-ada9e0da8627
Source feed: FDA_Inspections

> FDA inspection 1317130 of Blessings International, May 14, 2026. 2 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1317130
- Company Name: Blessings International
- Inspection Date: 2026-05-14
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1176594 - 2022-08-02](https://www.keypedia.com/records/fda_inspections/blessings-international/f24a5489-d612-4119-b5c0-0ee3a91651b7)
- FDA Inspection 1083996 - 2019-02-06
- [FDA Inspection 960759 - 2016-01-15](https://www.keypedia.com/records/fda_inspections/blessings-international/dcdb5c0e-44c2-4fb1-8b4e-33152ce49cd2)
- [FDA Inspection 839846 - 2013-07-09](https://www.keypedia.com/records/fda_inspections/blessings-international/46553a56-6ba7-401c-b456-93419f37769d)
- FDA Inspection 702083 - 2010-12-15

## Related Officers

- [Melissa M. Steiger](https://www.keypedia.com/people/melissa-m-steiger/513a7364-15df-474f-8a8a-b5c4ff1cf59f)

Company: https://www.keypedia.com/companies/blessings-international/ce6213e5-b5b4-40d8-95ba-137b1d3e0378

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9